ArteraNova Therapeutics Overview

  • Year Founded
  • 2025

Year Founded

  • Status
  • Private

  • Employees
  • 3

Employees

  • Latest Deal Type
  • Accelerator/​Inc

  • Investors
  • 2

ArteraNova Therapeutics General Information

Description

Developer of vascular therapeutics designed to treat arterial disease through targeted regenerative interventions. The company specializes in peptide-nanoparticle drug delivery platforms, drug-coated balloon technologies, vascular disease therapeutics, restenosis prevention, and precision cardiovascular treatments, enabling healthcare providers to address arterial re-narrowing while supporting natural vessel healing processes.

Contact Information

Website
arteranova.com
Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Corporate Office
  • MaRS Discovery District
  • 101 College Street, 14th floor
  • Toronto, Ontario M5G 0A3
  • Canada
Primary Industry
Biotechnology
Other Industries
Drug Delivery
Therapeutic Devices
Vertical(s)
Nanotechnology, Life Sciences
Corporate Office
  • MaRS Discovery District
  • 101 College Street, 14th floor
  • Toronto, Ontario M5G 0A3
  • Canada

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

ArteraNova Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Accelerator/Incubator 01-Apr-2026 Completed Pre-Clinical Trials
1. University Spin-Out 01-Dec-2025 Completed Generating Revenue
To view ArteraNova Therapeutics’s complete valuation and funding history, request access »

ArteraNova Therapeutics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

ArteraNova Therapeutics Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds
Health Innovation Hub Accelerator/Incubator
University of Toronto University
To view ArteraNova Therapeutics’s complete investors history, request access »

Ready to get started?

Request a free trial

ArteraNova Therapeutics FAQs

  • When was ArteraNova Therapeutics founded?

    ArteraNova Therapeutics was founded in 2025.

  • Where is ArteraNova Therapeutics headquartered?

    ArteraNova Therapeutics is headquartered in Toronto, Canada.

  • What is the size of ArteraNova Therapeutics?

    ArteraNova Therapeutics has 3 total employees.

  • What industry is ArteraNova Therapeutics in?

    ArteraNova Therapeutics’s primary industry is Biotechnology.

  • Is ArteraNova Therapeutics a private or public company?

    ArteraNova Therapeutics is a Private company.

  • What is ArteraNova Therapeutics’s current revenue?

    The current revenue for ArteraNova Therapeutics is .

  • Who are ArteraNova Therapeutics’s investors?

    Health Innovation Hub and University of Toronto have invested in ArteraNova Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process